CJC-1295 + Ipamorelin 10mg
The CJC-1295 and Ipamorelin combination is one of the most studied growth hormone secretagogue stacks in peptide research. CJC-1295 (without DAC) is a GHRH analogue that stimulates growth hormone release, while Ipamorelin is a selective GH secretagogue that amplifies that release with minimal effect on cortisol or prolactin. Research indicates this combination produces robust, pulsatile GH release, making it of significant interest for studies on muscle protein synthesis, fat metabolism, recovery, and age-related GH decline. 5mg CJC-1295 + 5mg Ipamorelin per vial. HPLC-verified. Lyophilised powder.
Only 5 left in stock
Crypto payments only — How to pay guide
Documentation
COA-backed
Source
Manufacturer COA
Shipping
Australia-wide
Payment
Crypto only
RetaLABS CJC-1295 + Ipamorelin 10mg is a lyophilised research vial combining two complementary growth hormone secretagogues — CJC-1295 (a GHRH analogue) and Ipamorelin (a selective GH secretagogue) — in a single preparation. Together, they target distinct receptor pathways to study GH pulse amplification and IGF-1 axis modulation.
Supplied as a white lyophilised powder. Each batch is accompanied by a Certificate of Analysis from the manufacturer. Shipped via Express Post Australia-wide — typically dispatched within 1–2 business days of confirmed crypto payment.
For reconstitution protocol see the Peptide Reconstitution Guide. For stack research overview see the CJC-1295 + Ipamorelin Research Guide.
Product Specifications
COA-backed, manufacturer-verified
Lyophilised powder (blend)
~3.3 kDa (GHRH analogue, 30 AA)
~711 Da (5 AA cyclic peptide)
GHRH-R + GHS-R1a dual agonist
-20°C (lyophilised), 2-8°C (reconstituted)
Bacteriostatic water or sterile saline
Research Use Only: These products are intended for laboratory research use only and are not approved for human consumption. All purchases are subject to our terms of service and local regulations.
Frequently Asked Questions
Everything you need to know about CJC-1295 + Ipamorelin 10mg